NCT02354352 Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE3
NCT02354131 Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02348983 Weight Loss Intervention in Long-Haul Truck Drivers: A Pilot Study Status COMPLETED Phase NA
NCT02334618 Insole Sensor to Determine Optimal Limb Loading in the Rehabilitation of Ankle Fractures Status COMPLETED Phase N/A
NCT02317783 Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment Status TERMINATED Phase PHASE2
NCT02311478 Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users Status COMPLETED Phase NA
NCT02311452 Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections Status COMPLETED Phase N/A
NCT02301767 MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02301546 Cognitive Training and Practice Effects in Mild Cognitive Impairment Status COMPLETED Phase NA
NCT02296346 Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis Status TERMINATED Phase NA
NCT02295475 Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome Status COMPLETED Phase PHASE4
NCT02286986 Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy Status COMPLETED Phase PHASE1
NCT02278783 Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer Status TERMINATED Phase PHASE2
NCT02272270 Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED) Status COMPLETED Phase PHASE1